Data
ImmunityBio, Inc. and the Russell 1000: candidate
ImmunityBio, Inc. (IBRX) reached "candidate" on its path from Nasdaq to Russell 1000.
Last updated: October 14, 2026, 8:20 AM ET· IBRX profile
Stage records come from the company's own releases and EDGAR filings; each is linked below. Nothing here predicts whether the listing completes.
The data
| Metric | Value |
|---|---|
| From → To | Nasdaq → Russell 1000 |
| Stage | candidate |
| Share price since announcement | — |
| Average volume, before → after | — |
| Insider buys, 90 days | 0 |
| Requirements check | — |
Stage history
candidate: 2026-06-26
The bottom line
Requirements are shown as meets or below against the exchange rulebook; they are facts about thresholds, not advice.